2020 Q4/Global Life Sciences
Rank | Chg | Organisation name | Overall |
|
---|---|---|---|---|
|
||||
1 | +1 |
Medivir Group
|
7.6 | |
|
||||
2 | -1 |
Apotex
|
7.1 | |
|
||||
3 | +0 |
EISAI UK
|
7.0 | |
|
||||
4 | +11 |
Galenica AG
|
6.7 | |
|
||||
5 | +6 |
Genus
|
6.5 | |
|
||||
6 | +2 |
Zambon
|
6.4 | |
|
||||
7 | -2 |
Stallergenes
|
6.4 | |
|
||||
8 | -4 |
Ligand Pharmaceuticals
|
6.3 | |
|
||||
9 | +1 |
SOBI
|
6.2 | |
|
||||
10 | +3 |
United Therapeutics
|
6.1 | |
|
||||
11 | +6 |
Debiopharm
|
5.9 | |
|
||||
12 | -6 |
Yakult UK
|
5.8 | |
|
||||
13 | +13 |
Mochida
|
5.8 | |
|
||||
14 | +9 |
Baxter Healthcare UK
|
5.7 | |
|
||||
15 | +6 |
Dainippon Sumitomo
|
5.5 | |
|
||||
16 | -9 |
Xoma
|
5.5 | |
|
||||
17 | +13 |
Zentiva
|
5.5 | |
|
||||
18 | +66 |
The Medicines Co
|
5.4 | |
|
||||
19 | -10 |
Kyorin Holdings
|
5.3 | |
|
||||
20 | +156 |
Kaneka
|
5.3 | |
|
||||
21 | +3 |
Meiji Holdings
|
5.2 | |
|
||||
22 | -6 |
Pfizer UK
|
5.1 | |
|
||||
23 | +2 |
Leo Pharma
|
5.1 | |
|
||||
24 | +9 |
Recordati
|
5.0 | |
|
||||
25 | +9 |
Bosnalijek
|
4.9 | |
|
||||
26 | -8 |
Baxter International
|
4.9 | |
|
||||
27 | +1 |
ALK-Abello
|
4.8 | |
|
||||
28 | +45 |
Takeda UK
|
4.8 | |
|
||||
29 | +10 |
Vernalis
|
4.8 | |
|
||||
30 | +0 |
Chugai UK
|
4.7 | |
|
||||
31 | +33 |
Astrazeneca
|
4.7 | |
|
||||
32 | +3 |
China Pharmaceutical Group
|
4.7 | |
|
||||
33 | -2 |
Leo Pharma UK
|
4.5 | |
|
||||
34 | -2 |
Otsuka Pharmaceuticals Europe
|
4.5 | |
|
||||
35 | +24 |
Kaken Pharmaceutical
|
4.5 | |
|
||||
36 | +41 |
Aptalis Pharma
|
4.5 | |
|
||||
37 | -18 |
Perrigo
|
4.5 | |
|
||||
38 | -18 |
Elan
|
4.5 | |
|
||||
39 | -12 |
Santen Europe
|
4.5 | |
|
||||
40 | +0 |
Wockhardt
|
4.5 | |
|
||||
41 | +100 |
Otsuka Pharmaceuticals
|
4.5 | |
|
||||
42 | -30 |
Mitsubishi Tanabe
|
4.4 | |
|
||||
43 | -2 |
Wockhardt UK
|
4.4 | |
|
||||
44 | +3 |
Alcon
|
4.4 | |
|
||||
45 | +13 |
Shionogi
|
4.4 | |
|
||||
46 | -24 |
Hetero
|
4.4 | |
|
||||
47 | -11 |
Toray Industries
|
4.4 | |
|
||||
48 | -3 |
Biotecnol
|
4.4 | |
|
||||
49 | -12 |
Bavarian Nordic
|
4.3 | |
|
||||
50 | +28 |
Forest
|
4.3 | |
|
Changes in rank are compared to 2020 Q3/Global Life Sciences. Since then, 5 sites entered the survey and 89 sites could not be included in the rankings (1 more since last time). Build your own. Report statistics.
Priorities Summary
The priorities for this organization are not currently available to view.
Contact Us